Niva Bupa Health Insurance Company Limited has been assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of “a-” (Excellent) by AM Best. The company also received an India National Scale Rating of aaa.IN (Exceptional), with a stable outlook. These ratings reflect strong balance sheet strength, adequate operating performance, and a neutral business profile.
Niva Bupa Receives Strong Credit Ratings
Niva Bupa Health Insurance Company Limited has announced that AM Best, a global credit rating agency, has assigned the company a Financial Strength Rating of A- (Excellent). Concurrently, the company has been assigned a Long-Term Issuer Credit Rating of “a-” (Excellent). Additionally, Niva Bupa secured an India National Scale Rating (NSR) of aaa.IN (Exceptional). The outlook for all these credit ratings has been assessed as stable.
Rating Rationale
According to AM Best, these ratings are a reflection of Niva Bupa’s very strong balance sheet strength. The agency also recognizes the company’s adequate operating performance, a neutral business profile, and appropriate enterprise risk management. The ratings also benefit from rating enhancement stemming from Niva Bupa’s parent company, British United Provident Association Limited (Bupa Group).
AM Best highlights that Niva Bupa’s balance sheet strength is underpinned by its risk-adjusted capitalisation, which was at the strongest level as of fiscal year-end (31 March) 2026. The agency anticipates this level of capitalisation to be maintained prospectively, supported by internal capital generation and earnings retention. Niva Bupa’s financial flexibility is considered strong, bolstered by shareholder contributions and access to capital markets.
The company’s operating performance has been assessed as adequate, with positive earnings reported over the last four fiscal years (2023-2026). Operating earnings are supported by robust investment returns that have helped offset underwriting losses. Niva Bupa’s underwriting performance has shown material improvement in recent years, attributed to a lower expense ratio as the company scaled its operations. In fiscal year 2026, Niva Bupa reported a return-on-equity ratio of 10.7% and a combined ratio of 102.0%.
Niva Bupa’s business profile is deemed neutral. The company is identified as a fast-growing health insurer in India, ranking third in the standalone health insurance sector. While holding a modest overall market share, it has a solid position in the retail health segment, offering a wide array of policies. The company also benefits from well-diversified distribution channels and strong digital capabilities.
Source: BSE
